Alternative Names
89Zr-DFO-girentuximab research-grade biosimilar; 89Zr-DFO-GmAb research-grade biosimilar; 89Zr-Girentuximab research-grade biosimilar; 89Zr-TLX250 research-grade biosimilar; 89ZR-TX250 research-grade biosimilar; Girentuximab-Zr-89 research-grade biosimilar; TLX250-CDX research-grade biosimilar; Zircaix research-grade biosimilar ;CA9 antibody; G250 antibody; MN antibody; Carbonic anhydrase 9 antibody; EC 4.2.1.1 antibody; Carbonate dehydratase IX antibody; Carbonic anhydrase IX antibody; CA-IX antibody; CAIX antibody; Membrane antigen MN antibody; P54/58N antibody; Renal cell carcinoma-associated antigen G250 antibody; RCC-associated antigen G250 antibody; pMW1 antibody
Immunogen
Recombinant Human CA9 protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.819
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.